Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

PHASE3RecruitingINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

June 16, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

February 28, 2025

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Lansoprazole

Lansoprazole 30mg (as 2 x 15mg capsules) twice daily, 12 hours apart, for 12 months. IMP should be taken at least 30 minutes before food.

OTHER

Matched placebo

Matched placebo 2 capsules twice daily, 12 hours apart, for 12 months. Treatment should be taken at least 30 minutes before food.

Trial Locations (1)

NR4 7UY

RECRUITING

Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich

Sponsors
All Listed Sponsors
collaborator

Norwich Clinical Trials Unit

UNKNOWN

lead

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

NCT04965298 - Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole | Biotech Hunter | Biotech Hunter